BOCCHIA MONICA | Professor page

Gozzetti, A., Pacelli, P., Caroni, F., Raspadori, D., Bestoso, E., Antonioli, E., et al. (2026). MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM. BRITISH JOURNAL OF HAEMATOLOGY [10.1111/bjh.70448]. - view more
Tatangelo, V., Carullo, G., Lopresti, L., Ulivieri, C., Brogi, S., Butini, S., et al. (2026). Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4. APOPTOSIS, 31(7) [10.1007/s10495-026-02393-0]. - view more
Gianesin, B., Zappu, A., Ferrero, G.B., Gaglioti, C.M., Santodirocco, M., Fania, G., et al. (2026). Real-world evidence supports the safety and efficacy profile of luspatercept in clinically complex and heavily iron-overloaded patients. BRITISH JOURNAL OF HAEMATOLOGY, 208(6), 2320-2325 [10.1111/bjh.70437]. - view more
Gavioli, F., Caggiano, V., Sbalchiero, J., Frassi, M., Crisafulli, F., Cavazzana, I., et al. (2026). VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries. SEMINARS IN ARTHRITIS AND RHEUMATISM, 77 [10.1016/j.semarthrit.2026.152932]. - view more
Del Prete, R., Tusha, V., Simon-Molas, H., Gazziero, V.A., Nardi, F., Drago, R., et al. (2026). IL21—STAT3 controls the pentose phosphate pathway to support metabolic reprogramming and tumor progression in chronic lymphocytic leukemia. HEMASPHERE, 10(1) [10.1002/hem3.70292]. - view more

All publications